Cairn Diagnostics

Cairn Diagnostics is a life sciences company dedicated to developing innovative, non-invasive diagnostic tests for gastroparesis, a condition that causes delayed gastric emptying. Founded by Kerry Bush, who has extensive experience in diagnostic tool development, the company aims to streamline the diagnostic process for complex gastrointestinal disorders with reliable and patient-friendly testing solutions. The flagship product is the FDA-approved 13C-Spirulina Gastric Emptying Breath Test (GEBT). This test measures the rate of solid-phase gastric emptying and serves as a non-radioactive, non-invasive alternative to traditional scintigraphy. It can be conveniently administered in a physician’s office or at home through telehealth, with results processed in a CLIA-certified lab and sent directly to the ordering physician. Cairn Diagnostics is headquartered in Brentwood, Tennessee, and operates under strict FDA regulations, ensuring high-quality standards for its diagnostic products. The company serves gastroenterologists, clinicians, and research centers, focusing on enhancing diagnostic workflows for gastrointestinal conditions.

• Employees21
• Founded2001